Papers
2
Total Citations
89
H-Index
1
About
Eric Lim is a leading thoracic surgeon and clinical researcher whose work has fundamentally reshaped the surgical management of lung cancer. His primary research areas center on minimally invasive thoracic surgery, patient-reported outcomes, and high-quality randomized controlled trials (RCTs) that challenge established surgical dogma. Lim’s most impactful contribution is the landmark VIOLET RCT (2022, 88 citations), which provided definitive evidence that video-assisted thoracoscopic surgery (VATS) lobectomy significantly improves patient recovery and physical function compared to traditional open lobectomy for early-stage lung cancer. This study has become a cornerstone for evidence-based practice, directly influencing surgical guidelines worldwide. Beyond lung cancer, Lim has also contributed to comparative analyses of minimally invasive techniques for gallbladder disease, including a 2025 meta-analysis on laparoscopic versus robotic cholecystectomy. His work is characterized by a rigorous focus on patient-centered outcomes, moving beyond simple operative metrics to measure what truly matters to patients: recovery, function, and quality of life. Through his leadership in practice-changing trials, Eric Lim has established himself as a pivotal figure in advancing the science and humanity of thoracic surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2